UBS Group

UBS Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

UBS Group’s Portfolio PEAR Stock Details PEAR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$10.4K	Buy
2022 Q4	$18.9K	Buy
2022 Q2	–	Sell
2022 Q1	$17K	Sell
2021 Q4	$27K	Buy